FOR RESEARCH & EDUCATIONAL PURPOSES ONLY - NOT MEDICAL ADVICE
PeptaBaseBack to Database
Nootropic & Neuropeptide

Semax

Typical Dosage
Intranasal: 400-800 mcg Injection: 100-300 mcg
Administration
Nasal • Injection
Half-Life
Short; often cited in minutes with longer pharmacodynamic effects

Mechanism of Action

Attention and executive-function research|Neuroprotection|BDNF/NGF signaling|Stroke recovery models

Research Protocol Summary

Evidence Level
Clinical Use / Mixed Literature
Typical Protocol Duration
10-30 days
Species Studied
Human • Rat
Administration Schedule
Daily
Timing Notes
AM

Studies

Research Availability

Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.

Open PubMed Search
Related resources
Nootropic & NeuropeptideEditorial PolicyEvidence MethodologyResearch GlossaryPeptide ComparisonsPeptide Calculator

Research Feedback

0 approved

For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.

Loading approved insights…

Related Peptides

ACTH
Nootropic & Neuropeptide
Adamax
Nootropic & Neuropeptide
DSIP
Nootropic & Neuropeptide
Noopept
Nootropic & Neuropeptide